» Articles » PMID: 22711097

Denosumab for Tumor-induced Hypercalcemia Complicated by Renal Failure

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2012 Jun 20
PMID 22711097
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia.

Tonon C, Silva T, Pereira F, Queiroz D, Favero Junior E, Martins D Med Sci Monit. 2022; 28:e935821.

PMID: 35217631 PMC: 8889795. DOI: 10.12659/MSM.935821.


Successful treatment with denosumab for two cases with hypercalcemia due to vitamin D intoxication and associated acute kidney injury.

Barth K, Sedivy M, Lindner G, Schwarz C CEN Case Rep. 2021; 11(1):141-145.

PMID: 34515963 PMC: 8810995. DOI: 10.1007/s13730-021-00643-5.


[Metabolic disorders as paraneoplastic syndromes].

Krug S, Michl P Internist (Berl). 2017; 59(2):114-124.

PMID: 29181551 DOI: 10.1007/s00108-017-0357-2.


Denosumab Therapy for Refractory Hypercalcemia Secondary to Squamous Cell Carcinoma of Skin in Epidermolysis Bullosa.

Giri D, Ramakrishnan R, Hayden J, Brook L, Das U, Mughal M World J Oncol. 2017; 6(2):345-348.

PMID: 29147430 PMC: 5649725. DOI: 10.14740/wjon907w.


Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.

Mirrakhimov A N Am J Med Sci. 2015; 7(11):483-93.

PMID: 26713296 PMC: 4683803. DOI: 10.4103/1947-2714.170600.